Related Experiment Video
Updated: Jul 25, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
The role of global risk assessment in hypertension therapy
S A Grover1, Brenda Hemmelgarn, Lawrence Joseph
1Centre for the Analysis of Cost-Effective Care, Division of Clinical Epidemiology, The Montreal General Hospital, 1650 Cedar Avenue, Montreal, Quebec, Canada. steven.grover@mcgill.ca
Insights
Cardiovascular disease risk assessment tools are needed for Canadians. This review identifies and evaluates global risk models, proposing a framework to help clinicians select the best tool for patient care.
Area of Science:
- Cardiology
- Preventive Medicine
- Biostatistics
Background:
- Cardiovascular disease (CVD) risk assessment is crucial for preventive therapy.
- Guidelines recommend targeting high-risk individuals for treatment.
- Accurate CVD risk estimation requires considering multiple factors like age, lipids, and smoking.
Purpose of the Study:
- To identify cardiovascular risk assessment tools suitable for Canadians.
- To evaluate the accuracy of existing models using Canadian data.
- To propose a framework for selecting appropriate risk tools.
Main Methods:
- Systematic review of global cardiovascular risk models.
- Evaluation of Framingham and Cardiovascular Life Expectancy models using a Canadian cohort.
- Development of a framework for tool selection.
Main Results:
- Several international risk models (Framingham, UKPDS, SCORE, Cardiovascular Life Expectancy) were identified as potentially applicable to Canadians.
- The Framingham and Cardiovascular Life Expectancy models showed varying accuracy when tested with Canadian data.
- A framework was proposed to guide healthcare professionals in choosing the most appropriate global risk tool.
Conclusions:
- No Canadian-specific global risk assessment model currently exists.
- International models can be used for Canadian risk assessment, but their accuracy needs consideration.
- A structured approach is needed to help clinicians select the best cardiovascular risk tool for their patients.
Abstract:
To maximize the benefits of preventive therapy, lipid and hypertension guidelines increasingly recommend that high-risk individuals be targeted for treatment. An individual's risk of developing cardiovascular disease depends on many risk factors, such as age, sex, blood pressure, blood lipid levels, body weight, physical fitness, smoking habits and familial predisposition. Multivariable statistical models have therefore been developed to better estimate the global risk of future coronary events and stroke. A Canadian model is not currently available because a prospective cohort of sufficient size has not been followed in Canada. Therefore, global risk assessment among Canadians can only be completed using models developed in the United States or Europe. In the present review, cardiovascular risk tools are identified that may be appropriate for Canadians, including those based on the Framingham model, the Cardiovascular Life Expectancy Model, the United Kingdom Prospective Diabetes Study (UKPDS) model and the Systematic COronary Risk Evaluation (SCORE) model. The accuracy of the Framingham model and the Cardiovascular Life Expectancy Model are also evaluated using data from a small, prospective Canadian cohort. Finally, a framework is proposed to assist health care professionals in choosing the global risk tool most appropriate for their patients.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

